156 related articles for article (PubMed ID: 28667493)
1. MiR-16-1 Targeted Silences Far Upstream Element Binding Protein 1 to Advance the Chemosensitivity to Adriamycin in Gastric Cancer.
Zhao D; Zhang Y; Song L
Pathol Oncol Res; 2018 Jul; 24(3):483-488. PubMed ID: 28667493
[TBL] [Abstract][Full Text] [Related]
2. Silence of long noncoding RNA UCA1 inhibits malignant proliferation and chemotherapy resistance to adriamycin in gastric cancer.
Shang C; Guo Y; Zhang J; Huang B
Cancer Chemother Pharmacol; 2016 May; 77(5):1061-7. PubMed ID: 27056384
[TBL] [Abstract][Full Text] [Related]
3. Silence of Long Noncoding RNA NEAT1 Inhibits Malignant Biological Behaviors and Chemotherapy Resistance in Gastric Cancer.
Zhang J; Zhao B; Chen X; Wang Z; Xu H; Huang B
Pathol Oncol Res; 2018 Jan; 24(1):109-113. PubMed ID: 28401449
[TBL] [Abstract][Full Text] [Related]
4. MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1.
Venturutti L; Cordo Russo RI; Rivas MA; Mercogliano MF; Izzo F; Oakley RH; Pereyra MG; De Martino M; Proietti CJ; Yankilevich P; Roa JC; Guzmán P; Cortese E; Allemand DH; Huang TH; Charreau EH; Cidlowski JA; Schillaci R; Elizalde PV
Oncogene; 2016 Dec; 35(48):6189-6202. PubMed ID: 27157613
[TBL] [Abstract][Full Text] [Related]
5. miR‑1 reverses multidrug resistance in gastric cancer cells via downregulation of sorcin through promoting the accumulation of intracellular drugs and apoptosis of cells.
Deng LM; Tan T; Zhang TY; Xiao XF; Gu H
Int J Oncol; 2019 Aug; 55(2):451-461. PubMed ID: 31268161
[TBL] [Abstract][Full Text] [Related]
6. Peiminine serves as an adriamycin chemosensitizer in gastric cancer by modulating the EGFR/FAK pathway.
Tang Q; Wang Y; Ma L; Ding M; Li T; Nie Y; Gu Z
Oncol Rep; 2018 Mar; 39(3):1299-1305. PubMed ID: 29328433
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-126 increases chemosensitivity in drug-resistant gastric cancer cells by targeting EZH2.
Wang P; Li Z; Liu H; Zhou D; Fu A; Zhang E
Biochem Biophys Res Commun; 2016 Oct; 479(1):91-6. PubMed ID: 27622325
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-17 inhibition overcomes chemoresistance and suppresses epithelial-mesenchymal transition through a DEDD-dependent mechanism in gastric cancer.
Wu DM; Hong XW; Wang LL; Cui XF; Lu J; Chen GQ; Zheng YL
Int J Biochem Cell Biol; 2018 Sep; 102():59-70. PubMed ID: 29953965
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of microRNA-34a enhances the DDP sensitivity of gastric cancer cells by modulating proliferation and apoptosis via targeting MET.
Zhang Z; Kong Y; Yang W; Ma F; Zhang Y; Ji S; Ma EM; Liu H; Chen Y; Hua Y
Oncol Rep; 2016 Oct; 36(4):2391-7. PubMed ID: 27513895
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of MicroRNA-147 Inhibits Cell Proliferation and Increases the Chemosensitivity of Gastric Cancer Cells to 5-Fluorouracil by Directly Targeting PTEN.
Shen J; Niu W; Zhang H; Jun M; Zhang H
Oncol Res; 2018 Jul; 26(6):901-911. PubMed ID: 28950928
[TBL] [Abstract][Full Text] [Related]
11. The function role of miR-181a in chemosensitivity to adriamycin by targeting Bcl-2 in low-invasive breast cancer cells.
Zhu Y; Wu J; Li S; Ma R; Cao H; Ji M; Jing C; Tang J
Cell Physiol Biochem; 2013; 32(5):1225-37. PubMed ID: 24335172
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-623 Targets Cyclin D1 to Inhibit Cell Proliferation and Enhance the Chemosensitivity of Cells to 5-Fluorouracil in Gastric Cancer.
Jiang L; Yang W; Bian W; Yang H; Wu X; Li Y; Feng W; Liu X
Oncol Res; 2018 Dec; 27(1):19-27. PubMed ID: 29495973
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA 494 increases chemosensitivity to doxorubicin in gastric cancer cells by targeting phosphodiesterases 4D.
Peng QP; Du DB; Ming Q; Hu F; Wu ZB; Qiu S
Cell Mol Biol (Noisy-le-grand); 2018 Dec; 64(15):62-66. PubMed ID: 30672438
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-200c regulates cisplatin resistance by targeting ZEB2 in human gastric cancer cells.
Jiang T; Dong P; Li L; Ma X; Xu P; Zhu H; Wang Y; Yang B; Liu K; Liu J; Xue J; Lv R; Su P; Kong G; Chang Y; Zhao C; Wang L
Oncol Rep; 2017 Jul; 38(1):151-158. PubMed ID: 28534959
[TBL] [Abstract][Full Text] [Related]
15. Silence of cancer susceptibility candidate 9 inhibits gastric cancer and reverses chemoresistance.
Shang C; Sun L; Zhang J; Zhao B; Chen X; Xu H; Huang B
Oncotarget; 2017 Feb; 8(9):15393-15398. PubMed ID: 28146436
[TBL] [Abstract][Full Text] [Related]
16. miR-493 mediated DKK1 down-regulation confers proliferation, invasion and chemo-resistance in gastric cancer cells.
Jia X; Li N; Peng C; Deng Y; Wang J; Deng M; Lu M; Yin J; Zheng G; Liu H; He Z
Oncotarget; 2016 Feb; 7(6):7044-54. PubMed ID: 26799283
[TBL] [Abstract][Full Text] [Related]
17. [Reversion of multidrug resistance of human gastric cancer SGC7901/DDP cells by E2F-1 gene silencing].
Lian C; Yang J; Wang X; Xie Y; Xiao Q
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):171-6. PubMed ID: 24785275
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of microRNA-127 reverses adriamycin resistance via cell cycle arrest and apoptosis sensitization in adriamycin-resistant human glioma cells.
Feng R; Dong L
Int J Clin Exp Pathol; 2015; 8(6):6107-16. PubMed ID: 26261488
[TBL] [Abstract][Full Text] [Related]
19. miR‑195‑5p regulates multi‑drug resistance of gastric cancer cells via targeting ZNF139.
Nie H; Mu J; Wang J; Li Y
Oncol Rep; 2018 Sep; 40(3):1370-1378. PubMed ID: 29956811
[TBL] [Abstract][Full Text] [Related]
20. miR‑92a contributes to cell proliferation, apoptosis and doxorubicin chemosensitivity in gastric carcinoma cells.
Tao XC; Zhang XY; Sun SB; Wu DQ
Oncol Rep; 2019 Jul; 42(1):313-320. PubMed ID: 31180538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
